PeterJamesFrancisMD
Ophthalmology • Portland, ORAssociate Professor, Ophthalmology, Oregon Health and Science University School of Medicine
Are you Dr. Francis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3375 SW Terwilliger Blvd
Portland, OR 97239Phone+1 503-494-7891Fax+1 503-494-7233
Summary
- Dr. Peter Francis, MD is an ophthalmologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Michigan, and Washington. He is affiliated with OHSU Hospital and St. Charles Prineville.
Education & Training
University of Southampton Faculty of MedicineClass of 1992
Certifications & Licensure
WA State Medical License Current
OR State Medical License 2009 - 2025
MI State Medical License 1990 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD Start of enrollment: 2007 May 01
- Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 54 citationsCongenital progressive polymorphic cataract caused by a mutation in the major intrinsic protein of the lens, MIP (AQP0).Peter J. Francis, Vanita Berry, Shomi S. Bhattacharya, Anthony T. Moore
The British Journal of Ophthalmology. 2000-12-01 - 618 citationsSeven new loci associated with age-related macular degenerationLars G. Fritsche, Wei Chen, Matthew Schu, Brian L. Yaspan, Yi Yu
Nature Genetics. 2013-04-01 - 59 citationsQuantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence Tomography.Amir H Hariri, Hong Yang Zhang, Alexander Ho, Peter J. Francis, Richard G. Weleber
JAMA Ophthalmology. 2016-06-01
Press Mentions
4D Molecular Therapeutics Expands Leadership Team with Appointments and Promotions of Key ExecutivesFebruary 19th, 2019
Correction of Potential Conflicts of Interest Disclosures, Author Affiliation, and Role of FunderSeptember 13th, 2018
New Trial Hopes to Restore Sight of Severe-Stage Retinitis Pigmentosa PatientsFebruary 24th, 2016
